Cost-Effectiveness of Pazopanib Compared to Sunitinib In the Treatment of Metastatic Renal Cell Carcinoma
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2215
https://www.valueinhealthjournal.com/article/S1098-3015(16)33581-1/fulltext
Title :
Cost-Effectiveness of Pazopanib Compared to Sunitinib In the Treatment of Metastatic Renal Cell Carcinoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33581-1&doi=10.1016/j.jval.2016.09.2215
First page :
A733
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2101